Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2026
|
| Sujets: | |
| Accès en ligne: | https://onlinelibrary.wiley.com/doi/10.1111/vec.70100 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1867002614351134720 |
|---|---|
| author | Esther Gómez‐Soto Miriam Guedra‐Allais Alice Le‐Gal Daria Starybrat |
| author_facet | Esther Gómez‐Soto Miriam Guedra‐Allais Alice Le‐Gal Daria Starybrat Esther Gómez‐Soto Miriam Guedra‐Allais Alice Le‐Gal Daria Starybrat |
| collection | Wiley Open Access |
| contents | Multicenter Retrospective Study of Xenotransfusion of Canine Plasma Products to Cats: 14 Cases (2022–2024) Esther Gómez‐Soto Miriam Guedra‐Allais Alice Le‐Gal Daria Starybrat Journal of Veterinary Emergency and Critical Care ABSTRACT Objective To determine the indications, transfusion protocols, transfusion reactions, and outcomes of cats that received canine plasma products. Design Retrospective, descriptive study from 2022 to 2024. Setting Multicenter study from one university teaching hospital and two private referral hospitals. Animals Fourteen client‐owned cats that were transfused with canine plasma products and had transfusion records available. Interventions None. Measurements and Main Results Fourteen cats received 16 canine plasma transfusions. The reasons for canine plasma xenotransfusion were confirmed coagulopathy (7/14), suspected coagulopathy (1/14), oncotic support (5/14), and severe hypovolemia (1/14). Six cats were found to be coagulopathic based on pretransfusion activated partial thromboplastin time (aPTT) and prothrombin time (PT). Three of these cats achieved normalization of both PT and aPTT after plasma xenotransfusion; one cat achieved normalization of PT only, and one cat had normalization of aPTT and mild prolongation of PT posttransfusion (<1.5‐fold elevation of the upper reference interval). The median volume of canine plasma products administered was 11.35 mL/kg (range: 5.25–31.9), and the median time in which the plasma xenotransfusion was completed was 3.9 h (range: 0.15–24). Only six cats received canine plasma products exclusively. Of these six cats, two (33.3%) were suspected to experience signs of acute transfusion reactions, categorized as acute respiratory distress. Five cats (35.7%) survived to discharge, six (42.9%) were euthanized, and three (21.4%) experienced cardiopulmonary arrest. Conclusions Canine plasma xenotransfusions to cats can be considered a life‐saving option in the absence of feline plasma products for the treatment of coagulopathies and colloidal support. However, the safety profile of canine plasma transfusions in cats remains to be determined. 10.1111/vec.70100 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1111/vec.70100 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_vec_70100 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2026 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Multicenter Retrospective Study of Xenotransfusion of Canine Plasma Products to Cats: 14 Cases (2022–2024) Esther Gómez‐Soto Miriam Guedra‐Allais Alice Le‐Gal Daria Starybrat Journal of Veterinary Emergency and Critical Care Multicenter Retrospective Study of Xenotransfusion of Canine Plasma Products to Cats: 14 Cases (2022–2024) Esther Gómez‐Soto Miriam Guedra‐Allais Alice Le‐Gal Daria Starybrat Journal of Veterinary Emergency and Critical Care ABSTRACT Objective To determine the indications, transfusion protocols, transfusion reactions, and outcomes of cats that received canine plasma products. Design Retrospective, descriptive study from 2022 to 2024. Setting Multicenter study from one university teaching hospital and two private referral hospitals. Animals Fourteen client‐owned cats that were transfused with canine plasma products and had transfusion records available. Interventions None. Measurements and Main Results Fourteen cats received 16 canine plasma transfusions. The reasons for canine plasma xenotransfusion were confirmed coagulopathy (7/14), suspected coagulopathy (1/14), oncotic support (5/14), and severe hypovolemia (1/14). Six cats were found to be coagulopathic based on pretransfusion activated partial thromboplastin time (aPTT) and prothrombin time (PT). Three of these cats achieved normalization of both PT and aPTT after plasma xenotransfusion; one cat achieved normalization of PT only, and one cat had normalization of aPTT and mild prolongation of PT posttransfusion (<1.5‐fold elevation of the upper reference interval). The median volume of canine plasma products administered was 11.35 mL/kg (range: 5.25–31.9), and the median time in which the plasma xenotransfusion was completed was 3.9 h (range: 0.15–24). Only six cats received canine plasma products exclusively. Of these six cats, two (33.3%) were suspected to experience signs of acute transfusion reactions, categorized as acute respiratory distress. Five cats (35.7%) survived to discharge, six (42.9%) were euthanized, and three (21.4%) experienced cardiopulmonary arrest. Conclusions Canine plasma xenotransfusions to cats can be considered a life‐saving option in the absence of feline plasma products for the treatment of coagulopathies and colloidal support. However, the safety profile of canine plasma transfusions in cats remains to be determined. 10.1111/vec.70100 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Multicenter Retrospective Study of Xenotransfusion of Canine Plasma Products to Cats: 14 Cases (2022–2024) |
| topic | Journal of Veterinary Emergency and Critical Care |
| url | https://onlinelibrary.wiley.com/doi/10.1111/vec.70100 |